Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,348
Closed -$90K 199
2021
Q2
$90K Buy
+1,348
New +$90.1K 0.02% 177
2019
Q2
Sell
-205,829
Closed -$1.37M 162
2019
Q1
$1.37M Buy
+205,829
New +$9.28M 0.33% 55
2018
Q4
Sell
-1,348
Closed -$55K 201
2018
Q3
$55K Hold
1,348
0.01% 170
2018
Q2
$54K Hold
1,348
0.01% 170
2018
Q1
$50K Hold
1,348
0.01% 172
2017
Q4
$58K Hold
1,348
0.02% 165
2017
Q3
$49K Hold
1,348
0.01% 177
2017
Q2
$61K Hold
1,348
0.02% 168
2017
Q1
$57K Hold
1,348
0.02% 170
2016
Q4
$54K Hold
1,348
0.02% 176
2016
Q3
$52K Hold
1,348
0.02% 168
2016
Q2
$47K Hold
1,348
0.02% 172
2016
Q1
$47K Buy
+1,348
New +$47K 0.02% 173

Other funds holding HOLX

Isthmus Partners's HOLX Position: Q3 2021 in Review

Isthmus Partners sold out of Hologic (HOLX) in Q3 2021, closing a stake of 1,348 shares — an estimated $90K sold.

Isthmus Partners first reported a position in HOLX in Q1 2016 and held it in 13 quarters. The position peaked at $1.37M in Q1 2019. 643 funds tracked by Wall St. Rank hold HOLX as of Q3 2021.

  • Isthmus Partners reported no remaining Hologic position as of Q3 2021 after selling out during the quarter.
  • Isthmus Partners sold 1,348 Hologic shares in Q3 2021, an estimated $90K.
  • Isthmus Partners first reported a position in Hologic in Q1 2016 and held it in 13 quarters.
  • Isthmus Partners's Hologic position peaked at $1.37M in Q1 2019.
  • 643 funds tracked by Wall St. Rank held Hologic as of Q3 2021.

Based on Isthmus Partners's 13F filing for Q3 2021, filed 10 Nov 2021.